Eam Global Investors LLC Viridian Therapeutics, Inc.\De Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$25.04 - $37.6 $727,211 - $1.09 Million
-29,042 Reduced 19.12%
122,864 $3.13 Million
Q4 2022

Feb 14, 2023
BUY
$18.78 - $29.74 $1.37 Million - $2.17 Million
73,096 Added 92.75%
151,906 $4.44 Million
Q3 2022

Nov 14, 2022
BUY
$10.7 - $25.5 $843,267 - $2.01 Million
78,810 New
78,810 $1.62 Million

Others Institutions Holding VRDN

# of Institutions
179
Shares Held
76.8M
Call Options Held
581K
Put Options Held
439K
View Full List

About Viridian Therapeutics, Inc.\DE

VRDN Quotes by TradingView
  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $806M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email